CClinicalTrials.gg
CompletedNCT03200899Updated Jul 10, 2024Results posted

Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis

An interventional study of MAPSS-MS and Usual Care plus computer games in Multiple Sclerosis, sponsored by University of Texas at Austin. Completed at 1 site in United States. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-07-10.

Sponsored by University of Texas at Austin · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 3 years 5 months after the study started (first participant enrolled Jan 2014, registered Jun 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
183
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The effects of multiple sclerosis (MS) on cognition, thought to occur in 50-75% of persons with MS, have gained increasing recognition as one of the major disabling symptoms of the disease. While numerous studies have addressed the emotional and physical impact of MS, little attention has been given to strategies that might help manage the cognitive changes commonly experienced by persons with MS. The proposed study will test a novel computer-assisted cognitive rehabilitation intervention, MAPSS-MS (Memory, Attention, \& Problem Solving Skills for Persons with MS). The MAPSS-MS integrates the powerful effects of group interventions to build self-efficacy for new cognitive compensatory strategies/behaviors with individual home-based computer-assisted training. The computer training will assist individuals to develop cognitive skills that they can apply to everyday life using the compensatory strategies learned in the class sessions. In the recently completed exploratory study with 61 persons with MS (R21NR011076), the eight-week MAPSS-MS intervention was acceptable and feasible and had medium to large effects on the use of compensatory strategies and performance on neuropsychological tests of verbal memory. The proposed study will test the refined MAPSS-MS intervention with a larger more diverse sample (N=180) across multiple sites, extend the period of post-intervention follow-up to 6 months and establish whether performance improvements on neuropsychological tests make the important transfer to improved neuro-cognitive functioning in everyday life.

The specific aims of this study are to: (1) Evaluate the efficacy of the novel MAPSS-MS cognitive rehabilitation intervention to improve overall neuro-cognitive competence in activities of daily living including verbal memory performance, use of compensatory cognitive strategies and performance on cognitive-related instrumental activities of daily living (IADL) among persons with MS; (2) Evaluate the efficacy of the MAPSS-MS intervention to improve self-efficacy and related aspects of cognitive performance (non-verbal learning/memory, information processing speed and attention, verbal fluency and complex scanning and tracking) among persons with MS; and (3) Determine the number of intervention participants who achieve and maintain their self-identified cognitive goals three and six months following the intervention. The effects of the intervention on outcome variables will be assessed using a randomized controlled trial design with a comparison group receiving usual care computer games. Measurements of study variables will occur at baseline, immediately after the MAPSS-MS intervention, and three months and six months after the intervention is complete. Statistical analysis will include descriptive statistics and HLM analysis to account for the nested design. The intent-to-treat approach will be used.

Public Health Statement: This research will provide new knowledge about an innovative intervention to improve memory, use of compensatory strategies, and performance of cognitive activities and instrumental activities of daily living for persons with MS. If effective, the intervention would provide a new and feasible approach to target a serious, debilitating problem commonly experienced by persons with MS.

02

Conditions studied

  • Multiple Sclerosis

Keywords

  • cognitive rehabilitation
03

In context

Multiple Sclerosis

3,460 studies on the registry are indexed under Multiple Sclerosis; 661 are open to participants now.

This study's enrollment of 183 is above the median of 50 across 2,342 interventional studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

University of Texas at Austin is the lead sponsor of 319 studies on the registry; 78 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 5 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Clinically definite diagnosis of MS;
  • Age 18 to 60;
  • Capable of understanding and complying with the study protocol;
  • Able to read and write in English;
  • Visual acuity of at least 20/70 with correction in order to work on the computer screen;
  • Stable disease at the time of entry into the study (relapse free for at least 90 days);
  • Subjective concerns about their cognitive functioning (based on the Perceived Deficits Questionnaire); and
  • Home internet access;

Exclusion criteria

Exclusion Criteria:

  • Other medical causes of dementia or other neurological disorders that may impact cognition or emotions;
  • Evidence of major psychiatric disorder; or
  • Major functional limitations that preclude them from participating in the study.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
183 participants (actual)

Study arms

  • Experimental
    Memory, Attention, Problem Solving Skills in MS (MAPSS-MS)

    Participants randomized to this arm receive the MAPSS-MS intervention. The MAPSS-MS is an an 8 week computer assisted cognitive rehabilitation intervention. The group based component of the intervention emphasizes use of compensatory cognitive strategies as well as lifestyle modifications to enhance cognition. Participants also complete home computer training (minimum 3 times per week for 45 minutes) using a special suite of games designed by Lumosity.

    Behavioral: MAPSS-MS

  • Active comparator
    Usual Care plus Computer games

    Participants randomized to this arm receive usual care and are referred to MY BRAIN GAMES web site.

    Other: Usual Care plus computer games

Interventions

  • BehavioralMAPSS-MS

    MAPSS-MS is a computer-assisted cognitive rehabilitation intervention. It is a combination of home computer training and 8-weeks of group sessions on lifestyle change and compensatory cognitive strategies.

  • OtherUsual Care plus computer games

    Participants assigned to this arm receive their usual medical care and referral to the "My Brain Games" website.

06

What researchers measure

Primary outcomes

  1. Neuro-cognitive Competence in Daily Living - California Verbal Learning Test-II

    Verbal memory performance (verbal learning and remembering) as measured by performance on the California Verbal Learning Test II (CVLT-II). Total score represents the number of words recalled from a 16 item list over 5 trials. Higher scores represent greater verbal learning and remembering. Scores can range from 0 to 80.

    Time frame: 6 months post-intervention

  2. Use of Compensatory Cognitive Strategies

    Scores on the Strategy Subscale of the Multi-Factorial Memory Memory Questionnaire. The subscale includes 19 various memory aids and strategies and respondents are asked to rate how frequently they used each strategy during the past 2 weeks using a 5 point scale (never to all the time). Scores can range from 0 to 76. HIgher scores indicate greater use of compensatory memory strategies.

    Time frame: 6 months post-intervention

  3. Cognitive-related Instrumental Activities of Daily Living (IADL) Among Persons With MS

    Scores on the Everyday Problems Test - Revised (EPT-R). This scale assess the cognitive ability to reason and solve problems encountered in daily living. The revised version included 30 items and scores can range from 0 to 30. HIgher scores indicate better performance on problem solving.

    Time frame: 6 months post intervention

Secondary outcomes

  1. Self-Efficacy

    Scores on the 17 item general self-efficacy scale. Respondents rate their confidence in their ability to affect outcomes in various contexts and situations using a 5-point Likert scale. Scores can range from 17 to 85 with higher scores representing greater perceived self-efficacy expectations.

    Time frame: 6 months post intervention

  2. Verbal Fluency

    Controlled Oral Word Association Test (COWAT) is a measure of verbal fluency and word finding. It requires participants to generate words from initial letters (normally F, A and S) under time constraints, normally 60 seconds per letter. The score reflects the number of words generated across the trials and can vary from 0 to the maximum number generated. Higher scores reflect a greater number of words and greater fluency and word finding.

    Time frame: 6 months post intervention

  3. Nonverbal Learning and Memory

    Brief Visuospatial Memory Test, 2nd ed (BVMT-R) asses visuospatial memory and was used as a measure of non-verbal learning and memory. The total recall score was used in this study and this score represents the sum of all valid items generated across learning trials 1-3. In each trial, 0-12 points can be obtained. The recognition (yes/no) is scored by one or zero points with a maximum of 12 points. The total score for the total recall ranges from 0 to 36. HIgher scores indicate better memory and recall.

    Time frame: 6 months post intervention

  4. Auditory Information Processing Speed and Flexibility

    The Paced Auditory Serial Addition Test (PASAT) - 3 second was used as the measure of auditory information processing speed and flexibility. Scores represent the number of correct responses during the 3 minute test and can range from 0 to 60. Higher scores indicate better information processing speed and flexibility.

    Time frame: 6 months post intervention

  5. Psychomotor Processing Speed

    The Symbol Digit Modalities Test (SDMT) was used to measure psychomotor processing speed, complex scanning and visual tracking. Respondents have 90 seconds to pair digits/numbers with abstract geometric symbols. Total scores represent the number of correct matches within the time period and can range from 0 to 110. Higher scores reflect better information processing speed.

    Time frame: 6 months post intervention

07

Results

Posted Jul 10, 2024

Participant flow

Participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas. Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newletters and websites.

Participant flow — Overall Study
MilestoneMemory, Attention, Problem Solving Skills in MS (MAPSS-MS)Usual Care Plus Computer Games
Started9390
T2 - immediately post-intervention8578
T3 - 3-months post-intervention8274
Completed8367
Not completed1023
Withdrew: Lost to follow-up1023

Outcome measures

PrimaryNeuro-cognitive Competence in Daily Living - California Verbal Learning Test-II

Verbal memory performance (verbal learning and remembering) as measured by performance on the California Verbal Learning Test II (CVLT-II). Total score represents the number of words recalled from a 16 item list over 5 trials. Higher scores represent greater verbal learning and remembering. Scores can range from 0 to 80.

Time frame:
6 months post-intervention
Reported as:
Mean · units on a scale
Neuro-cognitive Competence in Daily Living - California Verbal Learning Test-II
units on a scaleMemory, Attention, Problem Solving Skills in MS (MAPSS-MS)Usual Care Plus Computer Games
Neuro-cognitive Competence in Daily Living - California Verbal Learning Test-II56.1 ± 12.953.6 ± 12.9
Statistical analysis
  • Memory, Attention, Problem Solving Skills in MS (MAPSS-MS) vs Usual Care Plus Computer Games · ANCOVA · p = 0.926
PrimaryUse of Compensatory Cognitive Strategies

Scores on the Strategy Subscale of the Multi-Factorial Memory Memory Questionnaire. The subscale includes 19 various memory aids and strategies and respondents are asked to rate how frequently they used each strategy during the past 2 weeks using a 5 point scale (never to all the time). Scores can range from 0 to 76. HIgher scores indicate greater use of compensatory memory strategies.

Time frame:
6 months post-intervention
Reported as:
Mean · units on a scale
Use of Compensatory Cognitive Strategies
units on a scaleMemory, Attention, Problem Solving Skills in MS (MAPSS-MS)Usual Care Plus Computer Games
Use of Compensatory Cognitive Strategies40.2 ± 11.039.5 ± 11.2
Statistical analysis
  • Memory, Attention, Problem Solving Skills in MS (MAPSS-MS) vs Usual Care Plus Computer Games · ANCOVA · p = 0.750
PrimaryCognitive-related Instrumental Activities of Daily Living (IADL) Among Persons With MS

Scores on the Everyday Problems Test - Revised (EPT-R). This scale assess the cognitive ability to reason and solve problems encountered in daily living. The revised version included 30 items and scores can range from 0 to 30. HIgher scores indicate better performance on problem solving.

Time frame:
6 months post intervention
Reported as:
Mean · units on a scale
Cognitive-related Instrumental Activities of Daily Living (IADL) Among Persons With MS
units on a scaleMemory, Attention, Problem Solving Skills in MS (MAPSS-MS)Usual Care Plus Computer Games
Cognitive-related Instrumental Activities of Daily Living (IADL) Among Persons With MS24.2 ± 4.823.5 ± 4.4
Statistical analysis
  • Memory, Attention, Problem Solving Skills in MS (MAPSS-MS) vs Usual Care Plus Computer Games · ANCOVA · p = 0.129
SecondarySelf-Efficacy

Scores on the 17 item general self-efficacy scale. Respondents rate their confidence in their ability to affect outcomes in various contexts and situations using a 5-point Likert scale. Scores can range from 17 to 85 with higher scores representing greater perceived self-efficacy expectations.

Time frame:
6 months post intervention
Reported as:
Mean · units on a scale
Self-Efficacy
units on a scaleMemory, Attention, Problem Solving Skills in MS (MAPSS-MS)Usual Care Plus Computer Games
Self-Efficacy63.7 ± 11.161.1 ± 12.0
Statistical analysis
  • Memory, Attention, Problem Solving Skills in MS (MAPSS-MS) vs Usual Care Plus Computer Games · ANCOVA · p = 0.152
SecondaryVerbal Fluency

Controlled Oral Word Association Test (COWAT) is a measure of verbal fluency and word finding. It requires participants to generate words from initial letters (normally F, A and S) under time constraints, normally 60 seconds per letter. The score reflects the number of words generated across the trials and can vary from 0 to the maximum number generated. Higher scores reflect a greater number of words and greater fluency and word finding.

Time frame:
6 months post intervention
Reported as:
Mean · words generated
Verbal Fluency
words generatedMemory, Attention, Problem Solving Skills in MS (MAPSS-MS)Usual Care Plus Computer Games
Verbal Fluency39.5 ± 12.136.9 ± 11.9
Statistical analysis
  • Memory, Attention, Problem Solving Skills in MS (MAPSS-MS) vs Usual Care Plus Computer Games · ANCOVA · p = 0.037
SecondaryNonverbal Learning and Memory

Brief Visuospatial Memory Test, 2nd ed (BVMT-R) asses visuospatial memory and was used as a measure of non-verbal learning and memory. The total recall score was used in this study and this score represents the sum of all valid items generated across learning trials 1-3. In each trial, 0-12 points can be obtained. The recognition (yes/no) is scored by one or zero points with a maximum of 12 points. The total score for the total recall ranges from 0 to 36. HIgher scores indicate better memory and recall.

Time frame:
6 months post intervention
Reported as:
Mean · units on a scale
Nonverbal Learning and Memory
units on a scaleMemory, Attention, Problem Solving Skills in MS (MAPSS-MS)Usual Care Plus Computer Games
Nonverbal Learning and Memory21.9 ± 7.020.1 ± 6.7
Statistical analysis
  • Memory, Attention, Problem Solving Skills in MS (MAPSS-MS) vs Usual Care Plus Computer Games · ANCOVA · p = 0.297
SecondaryAuditory Information Processing Speed and Flexibility

The Paced Auditory Serial Addition Test (PASAT) - 3 second was used as the measure of auditory information processing speed and flexibility. Scores represent the number of correct responses during the 3 minute test and can range from 0 to 60. Higher scores indicate better information processing speed and flexibility.

Time frame:
6 months post intervention
Reported as:
Mean · units on a scale
Auditory Information Processing Speed and Flexibility
units on a scaleMemory, Attention, Problem Solving Skills in MS (MAPSS-MS)Usual Care Plus Computer Games
Auditory Information Processing Speed and Flexibility47.6 ± 11.945.9 ± 11.8
Statistical analysis
  • Memory, Attention, Problem Solving Skills in MS (MAPSS-MS) vs Usual Care Plus Computer Games · ANCOVA · p = 0.293
SecondaryPsychomotor Processing Speed

The Symbol Digit Modalities Test (SDMT) was used to measure psychomotor processing speed, complex scanning and visual tracking. Respondents have 90 seconds to pair digits/numbers with abstract geometric symbols. Total scores represent the number of correct matches within the time period and can range from 0 to 110. Higher scores reflect better information processing speed.

Time frame:
6 months post intervention
Reported as:
Mean · units on a scale
Psychomotor Processing Speed
units on a scaleMemory, Attention, Problem Solving Skills in MS (MAPSS-MS)Usual Care Plus Computer Games
Psychomotor Processing Speed54.6 ± 12.252.0 ± 12.4
Statistical analysis
  • Memory, Attention, Problem Solving Skills in MS (MAPSS-MS) vs Usual Care Plus Computer Games · ANCOVA · p = 0.045

Adverse events

Collected over 8 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Memory, Attention, Problem Solving Skills in MS (MAPSS-MS)0/93 (0%)0/93 (0%)0/93 (0%)
Usual Care Plus Computer Games0/90 (0%)0/90 (0%)0/90 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Memory, Attention, Problem Solving Skills in MS (MAPSS-MS)Usual Care Plus Computer GamesTotal
<=18 years000
Between 18 and 65 years9390183
>=65 years000
Age, Continuous
Age, Continuous(years)Memory, Attention, Problem Solving Skills in MS (MAPSS-MS)Usual Care Plus Computer GamesTotal
Mean49.8 ± 7.549.4 ± 8.549.6 ± 8.0
Sex: Female, Male
Sex: Female, Male(Participants)Memory, Attention, Problem Solving Skills in MS (MAPSS-MS)Usual Care Plus Computer GamesTotal
Female8080160
Male131023
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Memory, Attention, Problem Solving Skills in MS (MAPSS-MS)Usual Care Plus Computer GamesTotal
Hispanic or Latino9918
Not Hispanic or Latino8481165
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Memory, Attention, Problem Solving Skills in MS (MAPSS-MS)Usual Care Plus Computer GamesTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American171734
White7364137
More than one race011
Unknown or Not Reported3811
Region of Enrollment
Region of Enrollment(participants)Memory, Attention, Problem Solving Skills in MS (MAPSS-MS)Usual Care Plus Computer GamesTotal
United States9390183
Marital Status
Marital Status(Participants)Memory, Attention, Problem Solving Skills in MS (MAPSS-MS)Usual Care Plus Computer GamesTotal
Married5661117
Un-married372966
Employment Status
Employment Status(Participants)Memory, Attention, Problem Solving Skills in MS (MAPSS-MS)Usual Care Plus Computer GamesTotal
Full-time252853
Part-time538
Unemployed - Disability323971
Retired12517
Other8210
Not reported111324

3 further baseline measures are reported on the registry.

08

Study locations

1 site
  • The University of Texas at Austin
    Austin, Texas 78701, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Jan 7, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — Data files will be de-identified and data will be available on request to the investigators - estimated availability 2020

Supporting information: Study protocol, Sap, Analytic code

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 10, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03200899
Lead sponsor
University of Texas at Austin
Responsible party
Alexa Stuifbergen (Professor and Dean, University of Texas at Austin) — Principal investigator
First posted
Jun 27, 2017
Start date
Jan 2014
Primary completion
Mar 2018
Completion
Jun 2018
Results posted
Jul 10, 2024
Last update
Jul 10, 2024

Study contacts

Alexa Stuifbergen, PhD
principal investigator · University of Texas at Austin

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion